Navigation Links
Verenium Reports Financial Results For The Second Quarter And Six Months Ended June 30, 2012
Date:8/6/2012

tlement of a noteholder lawsuit, which was recorded as an offset to operating expenses.  In addition, operating expenses were elevated during the first quarter of 2012 for transaction costs associated with various financing alternatives the Company was pursuing. Overall, after the effect of the prior year legal fee reimbursement, ongoing general and administrative expenses have remained flat over the prior year, while research and development costs have increased, reflecting continued investment in pipeline products.

Gain on Sale of Oilseed Processing Business

On March 23, 2012, the Company entered into an asset purchase agreement with DSM for the purchase of the Company's oilseed processing business and concurrently entered into a license agreement, a supply agreement and a transition services agreement with DSM.  The aggregate consideration received by the Company was $37 million.  The gain on sale for the six months ended June 30, 2012 was calculated as the difference between the allocated consideration amount for the oilseed processing business, in accordance with authoritative accounting guidance, of $31.3 million and the net carrying amount of the purchased assets and liabilities and transaction costs.

Income (Loss) from Operations

Income from operations for the six months ended June 30, 2012 was $29.6 million compared to loss from operations of $6.0 million for the same period in 2011, on a GAAP accounting basis.  Adjusted for the impact of restructuring expenses and the gain on sale of the oilseed business of $31.3 million, the Company's non-GAAP pro-forma loss from operations was $1.7 million for the six months ended June 30, 2012 compared to $3.0 million for the same period in 2011.  The Company believes that excluding the impact of these items provides a more consistent measure of operating results.

Net Income from Continuing Operations

Net income from continuing ope
'/>"/>

SOURCE Verenium Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Verenium Corporation To Announce Second Quarter 2012 Financial Results
2. Verenium Announces EPA Authorization To Market Its Next-Generation Enzyme Breaker For Hydraulic Fracturing
3. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility
4. Verenium Corporation Named One Of The 2012 Best Places to Work in San Diego
5. Verenium Corporation To Announce First Quarter 2012 Financial Results
6. Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results
7. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
8. Verenium to Present at Baird Clean Technology Conference
9. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
10. Cadence Pharmaceuticals Reports Second Quarter 2012 Financial Results
11. Discovery Labs Reports Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013  Insero Health, Inc., a company developing natural ... related neurological disorders, is today reporting top-line results from ... in patients with drug-resistant epilepsy.  The data are being ... Xll meeting by Dr. Steven Schachter ... Scientific Advisory Board.  In this study, INS001 appeared safe ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 The paradigm ... complex biological systems that can help predict the adverse ... Dr. Sergey Stepaniants, Head of Computational Biology at the ... biology tools to ensure high-quality genomics when used as ... be applied to complex data sets to identify key ...
(Date:5/17/2013)... 2013 Rust removal is one of home ... items could be damaged. To help rust contractors make it ... no-scrubbing rust remover it called Rusterizer. It announced ... 10% discount. , My Cleaning Products explained that rust could ... by staining them. The first one, it said, happens ...
(Date:5/17/2013)... 2013 Tooth decay is an epidemic in ... of the disease. The World Health Organization says that worldwide, ... adults have cavities. What are the long-term effects of this ... strong connection between the oral bacterial imbalance and serious systemic ... rampant, yet it is also 100% preventable? Answer: there has ...
Breaking Biology Technology:Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... Inc. (OTC/BB: TBIO) today announced the following Webcast:What: ... Business Update Conference CallWhen: , Thursday, May 12, 2011 ... Live over the Internet -- Simply log on to ... 402-452-5400To access the call via telephone, call 800-895-0198 from ...
... Sciences, Inc. (NASDAQ: CALP ), a leading ... life sciences research for personalized medicine, will be hosting ... 17th and 18th.  This annual event brings together global ... the technologies and discoveries that are transforming the detection ...
... May 5, 2011 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... the development and commercialization of products for central nervous ... the first quarter ended March 31, 2011. ... have made to date in 2011," said Mihael H. ...
Cached Biology Technology:Transgenomic to Hold First Quarter Financial Results Conference Call on May 12, 2011 2Caliper Owners Group and Investor Meeting to Highlight Technologies Enabling Personalized Medicine 2Vanda Pharmaceuticals Reports First Quarter 2011 Results 2Vanda Pharmaceuticals Reports First Quarter 2011 Results 3Vanda Pharmaceuticals Reports First Quarter 2011 Results 4Vanda Pharmaceuticals Reports First Quarter 2011 Results 5Vanda Pharmaceuticals Reports First Quarter 2011 Results 6Vanda Pharmaceuticals Reports First Quarter 2011 Results 7Vanda Pharmaceuticals Reports First Quarter 2011 Results 8
(Date:5/16/2013)... , May 16, 2013 Reportlinker.com ... is available in its catalogue: ... Opportunities, 2018 http://www.reportlinker.com/p01181929/Global-Biometric-Systems-Market-Forecast--Opportunities-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Security_Systems ... old security practises such as photographs, passwords ... of biometric technologies in last few years. ...
(Date:5/15/2013)... In the largest clinical trial to date to examine ... carriers with diseases other than breast and ovarian cancer, ... against advanced pancreatic and prostate cancers. Results of the ... Medicine at the University of Pennsylvania and Sheba Medical ... the American Society of Clinical Oncology,s annual meeting in ...
(Date:5/15/2013)... frontier explorer and world-renowned filmmaker James Cameron has been ... Diego as the recipient of the 2013 Nierenberg Prize ... a presentation on his record-setting DEEPSEA CHALLENGE expedition and ... Friday, May 31, on the UC San Diego campus. ... probe the mysteries and promise of the deep sea ...
Breaking Biology News(10 mins):Global Biometric Systems Market Forecast & Opportunities, 2018 2Global Biometric Systems Market Forecast & Opportunities, 2018 3Global Biometric Systems Market Forecast & Opportunities, 2018 4Global Biometric Systems Market Forecast & Opportunities, 2018 5Global Biometric Systems Market Forecast & Opportunities, 2018 6Global Biometric Systems Market Forecast & Opportunities, 2018 7PARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations 2James Cameron to be publicly honored with Scripps Nierenberg Prize 2James Cameron to be publicly honored with Scripps Nierenberg Prize 3James Cameron to be publicly honored with Scripps Nierenberg Prize 4
... the latest issue of the journal Nature, scientists at ... of the National Institutes of Health (NIH) describe a ... lead to new ways of thinking about how to ... , Led by immunologist Ronald Germain, M.D., Ph.D., the ...
... A pig used for research at the University of ... will provide the first sequence of the swine genome ... $10 million grant from the U.S. Department of Agriculture ... , Lawrence B. Schook, a professor of animal sciences ...
... Scientists at The University of Texas at Austin have developed ... that surrounds bacteria and plays a role in infection and ... during the course of an infection, cloaking the bacteria from ... the sugars were too slow to catch these rapid changes. ...
Cached Biology News:Chemical guidance of T cells leads to immunologic memory and long-term immunity 2Chemical guidance of T cells leads to immunologic memory and long-term immunity 3Illinois pig to make history as source of first complete swine genome 2Scientists seek to unwrap the sweet mystery of the sugar coat on bacteria 2
Can be used for the quantitative recovery of small amounts of nucleic acids within dilute solutions. 5mg/ml...
... controls for monitoring Aldolase tests. 2 ... with targeted manufacturing values at 4 ... 3 IU/L. 30-day shelf life ... C. Level 1: 3 x 3 ...
APOPTAG® Plastic Coverslips are designed to be custom fitted to the specific APOPTAG® kit application. Each coverslip has 2.5 x 1 dimensions....
Recombinant Mouse sTNF RII/TNFRSF1B...
Biology Products: